Environmentally friendly iron-catalyzed cascade synthesis of 1,2,4-benzothiadiazine 1,1-dioxide and quinazolinone derivatives

Journal of Combinatorial Chemistry

Volumn 11, Issue 4, 2009, Pages 653-657

  Yang, Daoshan ^a,b   Fu, Hua ^a   Hu, Liming ^b   Jiang, Yuyang ^c   Zhao, Yufen ^a  

^a Tsinghua University   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTHIADIAZINE DERIVATIVE; IRON; OXIDE; QUINAZOLINONE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ECONOMICS; GREEN CHEMISTRY; METHODOLOGY; SYNTHESIS; PROCEDURES;

BENZOTHIADIAZINES; CATALYSIS; GREEN CHEMISTRY TECHNOLOGY; IRON; MOLECULAR STRUCTURE; OXIDES; QUINAZOLINONES;

EID: 67650680888     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc9000339     Document Type: Article

References (48)

1. (a) Mannhold, R. Med. Res. Rev. 2004, 24, 213.
2. (b) Coghlan, M. J.; Carroll, W. A.; Gopalakrishnan, M. J. Med. Chem. 2001, 44, 1627.
3. (c) de Tullio, P.; Becker, B.; Boverie, S.; Dabrowski, M.; Wahl, P.; Antoine, M.-H.; Somers, F.; Sebille, S.; Ouedraogo, R.; Hansen, J. B.; Lebrun, P.; Pirotte, B. J. Med. Chem. 2003, 46, 3342.
4. (d) Boverie, S.; Antoine, M.-H.; Somers, F.; Becker, B.; Sebille, S.; Ouedraogo, R.; Counerotte, S.; Pirotte, B.; Lebrun, P.; de Tullio, P. J. Med. Chem. 2005, 48, 3492.
5. (e) de Tullio, P.; Boverie, S.; Becker, B.; Antoine, M.-H.; Nguyen, Q.-A.; Francotte, P.; Counerotte, S.; Sebille, S.; Pirotte, B.; Lebrun, P. J. Med. Chem. 2005, 48, 4990.
6. Braghiroli, D.; Puia, G.; Cannaza, G.; Tait, A.; Parenti, C.; Lossi, G.; Maraldi, M. J. Med. Chem. 2002, 45, 2355.
7. (a) Bliss, T. V. P.; Collingridge, G. L. Nature 1993, 361, 31.
8. (b) Nagarajan, N.; Quast, C.; Boxall, A. R.; Shahid, M.; Rosenmund, C. Neuropharmacology 2001, 41, 650.
9. (a) Disanto, R.; Costi, R.; Artico, M.; Massa, S.; Morongiu, M. E.; Loi, A. G.; De Montis, A.; Localla, P. Antivir. Chem. Chemother. 1998, 9, 127.
10. (b) Arranz, M. I.; Diaz, J. A.; Ingate, S. T.; Witrrouw, M.; Pannecouque, C.; Balzarini, J.; De Clercq, E.; Vega, S. Bioorg. Med. Chem. 1999, 7, 2811.
11. (c) Martinez, A.; Gil, C.; Abasolo, M. I.; Casto, A.; Bruno, A. M.; Perez, C.; Preto, C.; Otero, J. J. Med. Chem. 2000, 43, 3218.
12. (d) Tait, A.; Luppi, A.; Ceamelli, C. J. Heterocycl. Chem. 2004, 41, 747.
13. (e) Tedesco, R.; Shaw, A. N.; Bambal, R.; Chai, D.; Concha, N. O.; Darcy, M. G.; Dhanak, D.; Fitch, D. M.; Gates, A.; Gerhardt, W. G.; Halegoua, D. L.; Han, C.; Hofmann, G. A.; Johnston, V. K.; Kaura, A. C.; Liu, N.; Keenan, R. M.; Lin-Goerke, J.; Sarisky, R. T.; Wiggall, K. J.; Zimmerman, M. N.; Duffy, K. J. J. Med. Chem. 2006, 49, 971.
14. (a) Martinez, A.; Castro, A.; Gil, C.; Miralpiex, M.; Segarra, V.; Domenech, T.; Beleta, J.; Palacios, J. M.; Ryder, H.; Miro, X.; Bonet, C.; Casacuberta, J. M.; Azorin, F.; Pina, B.; Puigdomenech, P. J. Med. Chem. 2000, 43, 683.
15. (b) Castro, A.; Abasolo, M. I.; Gil, C.; Segarra, V.; Martienz, A. Eur. J. Med. Chem. 2001, 36, 333.
16. (a) Yoshida, S.; Aoyagi, T.; Harada, S.; Matsuda, N.; Ikeda, T.; Naganawa, H.; Hamada, M.; Takeuchi, T. J. Antibiot. 1991, 44, 111.
17. (b) Ma, Z.-Z.; Hano, Y.; Nomura, T.; Chen, Y.-J. Heterocvcles 1997, 46, 541.
18. (c) Deng, Y.; Xu, R.; Ye, Y. J. Chin. Pharm. Sci. 2000, 9, 116.
19. (d) Wattanapiromsakul, C.; Forster, P. I.; Waterman, P. G. Phvtochemistry 2003, 64, 609.
20. (a) Witt, A.; Bergman, J. Curr. Org. Chem. 2003, 7, 659,
21. and references cited therein, (b) Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787, and references cited therein.
22. (a) Ma, Z.; Hano, Y.; Nomura, T. Heterocycles 2005, 65, 2203.
23. (b) Connolly, D. J.; Cusack, D.; O'Sullivan, T. P.; Guiry, P. J Tetrahedron 2005, 61, 10153.
24. For example, raltitrexed (Tomudex, marketed for colorectal cancer), ispinesib (phase II for solid tumors), and tempostatin (phase II for bladder cancer).
25. (a) Larksarp, C.; Alper, H. J. Org. Chem. 2000, 65, 2773.
26. (b) Kamal, A.; Reddy, K. S.; Prasad, B. R.; Babu, A. H.; Ramana, A. V. Tetrahedron Lett. 2004, 45, 6517.
27. Selected examples, see: (a) Roy, A. D.; Subramanian, A.; Roy, R. J. Org. Chem. 2006, 71, 382.
28. (b) Liu, J.-F.; Ye, P.; Zhang, B.; Bi, G.; Sargent, K.; Yu, L.; Yohannes, D.; Baldino, C. M. J. Org. Chem. 2005, 70, 6339.
29. (c) Liu, J.-F.; Kaselj, M.; Isome, Y.; Ye, P.; Sargent, K.; Sprague, K.; Cherrak, D.; Wilson, C. J.; Si, Y.; Yohannes, D.; Ng, S.-C. J. Comb. Chem. 2006, 8, 7.
30. (d) Yoo, C. L.; Fettinger, J. C.; Kurth, M. J. J. Org. Chem. 2005, 70, 6941.
31. For recent reviews on metal-catalyzed N-arylation, see: (a) Kunz, K.; Scholz, U.; Ganzer, D. Svnlett 2003, 2428.
32. (b) Ley, S. V.; Thomas, A. W. Angew. Chem. Int. Ed. 2003, 42, 5400.
33. (c) Beletskaya, I. P.; Cheprakov, A. V. Coord. Chem. Rev. 2004, 248, 2337.
34. (d) Evano, G.; Blanchard, N.; Toumi, M. Chem. Rev. 2008, 108, 3054.
35. (e) Corbert, J.-P.; Mignani, G. Chem. Rev. 2006, 106, 2651.
36. (f) Hartwig, J. F. Synlett 2006, 1283, and references cited therein.
37. Selected examples: (a) Hartwig, J. F. Angew. Chem., Int. Ed. 1998, 37, 2046.
38. (b) Muci, A. R.; Buchwald, S. L. Top. Curr. Chem. 2002, 219, 131.
39. (c) Anderson, K. W.; Tundel, R. E.; Ikawa, T.; Altman, R. A.; Buchwald, S. L. Angew. Chem. Int., Ed. 2006, 45, 6523.
40. (d) Ikawa, T.; Barder, T. E.; Biscoe, M. R.; Buchwald, S. L. J. Am. Chem. Soc. 2007, 129, 13001.
41. (a) Correa, A.; Bolm, C. Angew. Chem., Int. Ed. 2007, 46, 8862.
42. (b) Correa, A.; Elmore, S.; Bolm, C. Chem.-Eur. J. 2008, 14, 3527.
43. (c) Correa, A.; Bolm, C. Adv. Svnth. Catal. 2008, 350, 391.
44. (d) Guo, D.; Huang, H.; Xu, J.; Jiang, H.; Liu, H. Org. Lett. 2008, 10, 4513.
45. (a) Liu, X.; Fu, H.; Jiang, Y.; Zhao, Y. Angew. Chem. Int. Ed. 2009, 48, 348.
46. (b) Huang, C.; Fu, Y.; Fu, H.; Jiang, Y.; Zhao, Y. Chem. Commun. 2008, 6333.
47. (c) Yang, D.; Fu, H.; Hu, L.; Jiang, Y.; Zhao, Y. J. Org. Chem. 2008, 73, 7841.
48. Potewar, T. M.; Nadaf, R. N.; Daniel, T.; Lahoti, R. J.; Srinivasan, K. V. Synth. Commun. 2005, 35, 231.